- Home
- BATL vs KTTA Comparison
BATL vs KTTA Comparison
Compare BATL & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BATL | KTTA |
|---|---|---|
| Founded | 1987 | 2020 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 18.9M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | BATL | KTTA |
|---|---|---|
| Price | $4.19 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 10.3M | 376.3K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $166,043,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.28 |
| 52 Week High | $29.70 | $2.34 |
Technical Indicators
Market Signals| Indicator | BATL | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 50.36 |
| Support Level | $1.23 | $0.67 |
| Resistance Level | $6.18 | $0.88 |
| Average True Range (ATR) | 1.58 | 0.07 |
| MACD | -1.05 | 0.00 |
| Stochastic Oscillator | 6.34 | 75.83 |
Price Performance
Historical ComparisonAbout BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).